Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis

Clinical efficacy and computed tomography diagnostic value of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis

Abstract Objective This study investigated the clinical efficacy of bedaquiline‐containing regimens in the treatment of drug‐resistant pulmonary tuberculosis and the diagnostic value of computed tomography (CT). Methods We retrospectively analyzed the clinical diagnosis, treatment, and CT imaging da...

Full description

Saved in:

Bibliographic Details
Main Authors:	Saiduo Liu, Xinchun Ye, Fang Cheng, Kaijia Wu, Jiandan Yu, Hongye Ning, Jichan Shi, Hongzhou Lu, Wei Chen
Format:	Article
Language:	English
Published:	Wiley 2024-09-01
Series:	iLabmed
Subjects:	bedaquiline tablets computed tomography drug‐resistant pulmonary tuberculosis efficacy pulmonary tuberculosis
Online Access:	https://doi.org/10.1002/ila2.57
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Immediate and Postponed Results of Short-Course Chemotherapy Regimens Containing Bedaquiline in Tuberculosis Patients with Multiple Drug Resistance
by: P. N. Golubchikov, et al.
Published: (2023-08-01)

The Profile of Multidrug Tuberculosis Regimen and Treatment Outcomes in Pulmonary MDR-TB Patients at the Tertiary Referral Hospital Dr. Soetomo, East Java, Indonesia: A Seven-Year Retrospective Study on Bedaquiline
by: Muhamad Frendy Setyawan, et al.
Published: (2024-01-01)

The multivariate analysis of results of bedaquiline use in the therapy of MDR/XDR pulmonary tuberculosis
by: N. V. Stavitskaya, et al.
Published: (2020-08-01)

Tolerability and Efficacy of Chemotherapy Containing Bedaquiline in Patients with Multiple Drug Resistant Pulmonary Tuberculosis
by: O. V. Filinyuk, et al.
Published: (2022-10-01)

Efficacy and safety of chemotherapy regimens with bedaquiline in patients with respiratory tuberculosis: immediate and final results
by: S. E. Borisov, et al.
Published: (2019-05-01)

Experience of using bedaquiline in the treatment of pulmonary tuberculosis patients with multiple drug resistance
by: T. I. Morozova, et al.
Published: (2016-02-01)

Cost-effectiveness of bedaquiline in MDR and XDR tuberculosis in Italy
by: Luigi R. Codecasa, et al.
Published: (2017-01-01)

Use of bedaquiline in the chemotherapy regimen for multiple drug resistant tuberculosis in the HIV positive patient
by: N. D. Pirogova, et al.
Published: (2019-11-01)

Treatment Outcomes for Drug-Resistant Tuberculosis Patients on Bedaquiline-Based Regimens in a Mostly Rural South Africa
by: Rukasha I, et al.
Published: (2025-04-01)

Experience of treating extensive drug resistant tuberculosis patients including continuous use of bedaquiline, in Tomsk Region: immediate and postponed results
by: P. N. Golubchikov, et al.
Published: (2019-09-01)

Effectiveness and Safety of the Regimens Containing Bedaquiline in Patients with TB and HIV-infection
by: S. B. Borisova, et al.
Published: (2024-11-01)

Bedaquiline resistance in Mycobacterium tuberculosis during antimycobacterial therapy and its impact on clinical outcomes (clinical cases)
by: O. M. Raznatovska, et al.
Published: (2023-03-01)

Vitamin C potentiates the killing of Mycobacterium tuberculosis by bedaquiline through metabolic disruption
by: Catherine Vilchèze, et al.
Published: (2025-08-01)

Pyrazinamide Resistance: A Major Cause of Switching Shorter to Longer Bedaquiline-based Regimens in Multidrug-resistant Tuberculosis Patients
by: Oki Nugraha Putra, et al.
Published: (2024-12-01)

Results of treatment with bedaquiline containing regimens of MDR/XDR tuberculosis patients including those with concurrent HIV infection (the experience of Leningrad Region)
by: T. I. Danilova, et al.
Published: (2020-10-01)

Efficacy and Adverse Event Profile in Patients Receiving “Shorter Oral Bedaquiline-containing Multidrug-resistant/Rifampicin-resistant Tuberculosis Regimen” in a Tertiary Care Hospital in Eastern India
by: Hindol Mondal, et al.
Published: (2025-07-01)

Prevalence of bedaquiline resistance in patients with drug-resistant tuberculosis: a systematic review and meta-analysis
by: Xinyang Hu, et al.
Published: (2025-05-01)

EXPERIENCE OF USING BEDAQUILINE AND LINEZOLID IN THE INTEGRAL TREATMENT OF THE PULMONARY TUBERCULOSIS PATIENT WITH EXTENSIVE DRUG RESISTANCE OF M. TUBERCULOSIS
by: E. M. Zhukova, et al.
Published: (2016-10-01)

Bedaquiline Efficacy in the Russian Federation: Meta-analysis with a Random Effects Model
by: A. A. Starshinova, et al.
Published: (2023-07-01)

Efficacy and safety of bedaquiline in treatment regimens in patients TB/HV co-infection in the Udmurt Republic
by: O. E. Russkikh, et al.
Published: (2023-04-01)

Bedaquiline Effect on QT Interval of Drugs-Resistant Tuberculosis Patients: Real World Data
by: I Gusti Agung Ayu Putu Sri Darmayani, et al.
Published: (2022-09-01)

Bedaquiline practice in treatment of extensively drug-resistant mycobacterium tuberculosis in children: Clinical cases
by: A. A. Akzhigitova, et al.
Published: (2022-05-01)

THE EFFECT OF DIFFERENT TB DRUGS AND ANTIMICROBIAL AGENTS ON THE EFFICIENCY OF TREATMENT OF TUBERCULOSIS PATIENTS WITH MULTIPLE DRUG RESISTANCE
by: I. A. Vasilyeva, et al.
Published: (2017-11-01)

IMPACT OF BEDAQUILINE ON THE EFFICIENCY OF COMPREHENSIVE THERAPY OF RESPIRATORY TUBERCULOSIS
by: M. N. Kondakova, et al.
Published: (2018-07-01)

Hepatic safety of pretomanid- and pyrazinamide-containing regimens in TB Alliance clinical trials
by: J. Nedelman, et al.
Published: (2025-08-01)

EXPERIENCE OF USING BEDAQUILINE IN THE TREATMENT OF PULMONARY TUBERCULOSIS PATIENTS WITH MULTIPLE ANDEXTENSIVE DRUG RESISTANCE
by: N. M. Konovаlovа, et al.
Published: (2018-01-01)

EFFICIENCY OF CHEMOTHERAPY WITH BEDAQUILINE IN DRUG RESISTANT PULMONARY TUBERCULOSIS PATIENTS
by: A. M. Tikhonov, et al.
Published: (2018-03-01)

Investigation of delamanid, bedaquiline, and linezolid resistance rates and related gene mutations in multidrug-resistant Mycobacterium tuberculosis in regional tuberculosis reference laboratories of Iran
by: Nazanin Ahmad Khosravi, et al.
Published: (2025-08-01)

High Prevalence of atpE Mutations in Bedaquiline-Resistant Mycobacterium tuberculosis Isolates, Russia
by: Danila Zimenkov, et al.
Published: (2025-03-01)

Methodology of the Treatment of Pulmonary Tuberculosis
by: Frayt V., et al.
Published: (2013-03-01)

Treatment success and mortality among people with multi-drug resistant and rifampicin resistant-tuberculosis on bedaquiline-based regimen at three referral hospitals in Uganda: A retrospective analysis
by: Lodiong Jackson Dumo Lodiong, et al.
Published: (2024-12-01)

Experience of using two courses of bedaquiline in the adolescent with extensive drug resistant fibrous cavernous tuberculosis
by: L. V. Pаnovа, et al.
Published: (2019-08-01)

New drugs in the treatment of drug-resistant tuberculosis in children. Experience with the use of delamanid in combination with bedaquiline
by: Ekaterina Sokolskaya, et al.
Published: (2024-12-01)

A clinical case of successful combined treatment of a patient with fibrous cavernous pulmonary tuberculosis and extensive drug resistance
by: P. N. Golubchikov, et al.
Published: (2020-07-01)

Adverse Drug Reactions in Multidrug-resistant Tuberculosis Patients on Longer Bedaquiline-based Regimen at a Tertiary Care Center in Mumbai
by: Abhishek Saini, et al.
Published: (2025-07-01)

Diversity of Mycobacterium tuberculosis Complex Lineages Associated with Pulmonary Tuberculosis in Southwestern, Uganda
by: Lisa, Nkatha Micheni, et al.
Published: (2021)

Sociodemographic characteristics of patients with pulmonary and extrapulmonary tuberculosis
by: A. V. Osadchiy, et al.
Published: (2015-02-01)

EXPERIENCE OF USING BEDAQUILINE IN THE MULTIMODALITY THERAPY OF TUBERCULOSIS PATIENTS WITH CONCURRENT HIV INFECTION
by: G. S. BALASANYANTS
Published: (2017-10-01)

Which fluoroquinolone is safer when combined with bedaquiline for tuberculosis treatment: evidence from FDA Adverse Event Reporting System database from 2013 to 2024
by: Sheng Wei, et al.
Published: (2024-12-01)

Long-term results of chemotherapy of tuberculosis with a widespread drug-resistant pathogen using bedaquiline
by: A. Yu. Chernikov, et al.
Published: (2023-04-01)